Increasing influenza and pneumococcal vaccination rates in high risk groups in one primary care trust as part of a clinical governance programme

2003 ◽  
Vol 8 (3) ◽  
pp. 200-207 ◽  
Author(s):  
A. Niroshan Siriwardena ◽  
Tracy Wilburn ◽  
Louise Hazelwood
Vaccines ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 123
Author(s):  
Álvaro Sosa Liprandi ◽  
Ezequiel José Zaidel ◽  
Ricardo Lopez Santi ◽  
John Jairo Araujo ◽  
Manuel Alfonso Baños González ◽  
...  

Background: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. Methods: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. Results: 4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59, p < 0.01) but without gender difference. Vaccination rates were greater in higher-risk groups (65+, diabetics, heart failure), but not in coronary artery disease patients. In the Southern cone, the rate of IV and PV was approximately double that in the tropical regions of the Americas. In a multivariate model, geographic zone (IV = OR 2.02, PV = OR 2.42, p < 0.001), age (IV = OR 1.023, PV = OR 1.035, p < 0.001), and incomes (IV = OR 1.28, PV = OR 1.58, p < 0.001) were predictors for vaccination. Conclusions: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.


2011 ◽  
Vol 14 (3) ◽  
pp. A121
Author(s):  
M. DiBonaventura ◽  
J.S. Wagner ◽  
A. Goren

2016 ◽  
Vol 144 (11) ◽  
pp. 2290-2294 ◽  
Author(s):  
R. RODRÍGUEZ-FERNÁNDEZ ◽  
A. B. MARTÍNEZ-LÓPEZ ◽  
J. PÉREZ-MORENO ◽  
M. I. GONZÁLEZ-SÁNCHEZ ◽  
F. GONZÁLEZ-MARTÍNEZ ◽  
...  

SUMMARYInfluenza vaccination has been shown to be the most effective preventive strategy to reduce influenza-related morbidity and mortality in high-risk groups. Despite healthcare personnel (HCP) being considered part of such high-risk groups, their vaccination coverage is low in Europe. In January 2012, we distributed an 18-question survey regarding influenza vaccination to HCP at Gregorio Marañon Paediatric Hospital, in Madrid, Spain. After we documented that only ~30% of HCP were vaccinated an educational programme was implemented in October 2012 before the next influenza season. In January 2013, the same survey delivered again to all HCP documented a significant increase in vaccination rates (from 30% to 40%, P = 0·007) mainly among physicians and for patients' protection. In summary we found that a simple and inexpensive educational programme significantly improved the uptake of influenza vaccination in HCP in our centre. Nevertheless, vaccination rates remained low, and broader and updated campaigns are needed to overcome perception barriers.


2008 ◽  
Vol 107 ◽  
pp. S118-S119
Author(s):  
K.D. Baas⁎ ◽  
K.A. Wittkampf ◽  
H.C. van Weert ◽  
P. Lucassen ◽  
J. Huyser ◽  
...  

2005 ◽  
Vol 26 (11) ◽  
pp. 882-890 ◽  
Author(s):  
Thomas R. Talbot ◽  
Suzanne F. Bradley ◽  
Sara E. Cosgrove ◽  
Christian Ruef ◽  
Jane D. Siegel ◽  
...  

AbstractInfluenza causes substantial morbidity and mortality annually, particularly in high-risk groups such as the elderly, young children, immunosuppressed individuals, and individuals with chronic illnesses. Healthcare-associated transmission of influenza contributes to this burden but is often under-recognized except in the setting of large outbreaks. The Centers for Disease Control and Prevention has recommended annual influenza vaccination for healthcare workers (HCWs) with direct patient contact since 1984 and for all HCWs since 1993. The rationale for these recommendations is to reduce the chance that HCWs serve as vectors for healthcare-associated influenza due to their close contact with high-risk patients and to enhance both HCW and patient safety. Despite these recommendations as well as the effectiveness of interventions designed to increase HCW vaccination rates, the percentage of HCWs vaccinated annually remains unacceptably low. Ironically, at the same time that campaigns have sought to increase HCW vaccination rates, vaccine shortages, such as the shortage during the 2004-2005 influenza season, present challenges regarding allocation of available vaccine supplies to both patients and HCWs. This two-part document outlines the position of the Society for Healthcare Epidemiology of America on influenza vaccination for HCWs and provides guidance for the allocation of influenza vaccine to HCWs during a vaccine shortage based on influenza transmission routes and the essential need for a practical and adaptive strategy for allocation. These recommendations apply to all types of healthcare facilities, including acute care hospitals, long-term-care facilities, and ambulatory care settings.


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Carrie McAdam-Marx ◽  
Casey Tak ◽  
Tanaz Petigara ◽  
Nathan W. Jones ◽  
Minkyoung Yoo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document